Watch CDIO. Know when insiders buy.
One email the day a filing lands. Free.
CDIO
Cardio Diagnostics Holdings, Inc.
2.07
+0.11 +5.61%
USD · close Sep 9
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
1
FLAG · shorts 1
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $6.1MP/E —DIV YIELD —FCF YIELD -95.08%REV TTM $14K −25.9%NET INCOME −$6.5MNET CASH —52W 1.05 – 6.55SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $5K | −28.3% | — | −$1.5M | −$1.5M | — | -0.51 | −$1.3M | $0 | −$1.3M | Aug 7 |
| Q1 2026 · Mar 31 | $3K | +185.1% | — | −$1.8M | −$1.8M | — | -0.63 | −$1.6M | $2K | −$1.6M | May 15 |
| Q4 2025 · Dec 31derived | $4K | −21.2% | — | −$1.5M | −$1.5M | — | -0.80 | −$1.4M | $0 | −$1.4M | Mar 13 |
| Q3 2025 · Sep 30 | $3K | −56.6% | — | −$1.7M | −$1.7M | — | -0.98 | −$1.4M | $163K | −$1.6M | Nov 12 |
| Q2 2025 · Jun 30 | $7K | −5.0% | — | −$1.7M | −$1.7M | — | -0.97 | −$1.6M | $19K | −$1.6M | Aug 7 |
| Q1 2025 · Mar 31 | $940 | −94.1% | — | −$1.6M | −$1.6M | — | -0.97 | −$1.4M | $6K | −$1.4M | May 15 |
| Q4 2024 · Dec 31derived | $5K | −15.0% | — | −$1.5M | −$1.5M | — | -0.28 | −$1.4M | $4K | −$1.4M | Mar 13 |
| Q3 2024 · Sep 30 | $7K | −34.4% | — | −$1.4M | −$1.4M | — | -1.73 | −$1.2M | $23K | −$1.2M | Nov 12 |
| Q2 2024 · Jun 30 | $8K | — | — | −$1.3M | −$1.3M | — | -1.71 | −$1.2M | $168K | −$1.4M | Aug 14 |
| Q1 2024 · Mar 31 | $16K | — | — | −$4.2M | −$4.2M | — | -5.93 | −$1.2M | $20K | −$1.3M | May 15 |
| Q4 2023 · Dec 31derived | $5K | — | — | −$1.5M | −$1.4M | — | 0.00 | −$1.7M | $537K | −$2.2M | Mar 20 |
| Q3 2023 · Sep 30 | $10K | — | — | −$1.4M | −$1.9M | — | -0.16 | −$1M | $13K | −$1.1M | Nov 13 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $15K | — | −$6.5M | −$6.5M | -43832.5% | -3.71 | −$5.7M | $187K | −$5.9M | — | — |
| FY2024 · to Dec 31 | $35K | — | −$8.4M | −$8.4M | -24028.2% | -9.35 | −$5M | $215K | −$5.2M | — | — |
| FY2023 · to Dec 31 | $17K | — | −$7.2M | −$8.4M | -49087.8% | -0.66 | −$5.7M | $576K | −$6.2M | — | — |
| FY2022 · to Dec 31 | $950 | — | −$4.5M | −$4.7M | -490630.0% | -1.51 | −$5.1M | — | — | — | — |
| FY2021 · to Dec 31 | $901 | — | −$620K | −$620K | -68862.2% | -0.53 | −$585K | — | — | — | — |
Every number comes from Cardio Diagnostics Holdings, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.